Impact of antigen identification on transplant free survival in interstitial lung disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Impact of antigen identification on transplant free survival in interstitial lung disease ; volume:23 ; number:1 ; day:26 ; month:10 ; year:2023 ; pages:1-6 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (26.10.2023), 1-6, 12.2023
- Urheber
-
Kypreos, Margaret
Batra, Kiran
Glazer, Craig S.
Adams, Traci N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02724-w
- URN
-
urn:nbn:de:101:1-2024020512163759970645
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kypreos, Margaret
- Batra, Kiran
- Glazer, Craig S.
- Adams, Traci N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases
Post-lung transplant outcomes of connective tissue disease-related interstitial lung diseases compared with idiopathic interstitial pneumonia: a single-center experience in Japan
High-resolution computed tomography pattern of usual interstitial pneumonia or nonspecific interstitial pneumonia in interstitial lung disease: Relationship to survival
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Drug induced interstitial lung disease
Respiratory bronchiolitis-interstitial lung disease
Interstitial lung diseases in children
Clinical Atlas of Interstitial Lung Disease
Serum biomarkers in interstitial lung diseases
Progression of fibrosing interstitial lung disease
Management of Fibrosing Interstitial Lung Diseases
Comorbidities in unclassifiable interstitial lung disease
Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases
Post-lung transplant outcomes of connective tissue disease-related interstitial lung diseases compared with idiopathic interstitial pneumonia: a single-center experience in Japan
High-resolution computed tomography pattern of usual interstitial pneumonia or nonspecific interstitial pneumonia in interstitial lung disease: Relationship to survival
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Drug induced interstitial lung disease
Respiratory bronchiolitis-interstitial lung disease
Interstitial lung diseases in children
Clinical Atlas of Interstitial Lung Disease
Serum biomarkers in interstitial lung diseases
Progression of fibrosing interstitial lung disease
Management of Fibrosing Interstitial Lung Diseases
Comorbidities in unclassifiable interstitial lung disease
Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases
Post-lung transplant outcomes of connective tissue disease-related interstitial lung diseases compared with idiopathic interstitial pneumonia: a single-center experience in Japan
High-resolution computed tomography pattern of usual interstitial pneumonia or nonspecific interstitial pneumonia in interstitial lung disease: Relationship to survival
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Drug induced interstitial lung disease
Respiratory bronchiolitis-interstitial lung disease
Interstitial lung diseases in children
Clinical Atlas of Interstitial Lung Disease
Serum biomarkers in interstitial lung diseases
Progression of fibrosing interstitial lung disease
Management of Fibrosing Interstitial Lung Diseases